Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61,709,822
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
65,187,064
-
Shares change
-
+2,830,636
-
Total reported value, excl. options
-
$971,256,923
-
Value change
-
+$41,504,855
-
Put/Call ratio
-
44%
-
Number of buys
-
64
-
Number of sells
-
50
-
Price
-
$14.90
Institutional Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q1 2024
155 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of 31 Mar 2024.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) had 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,187,064 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, First Light Asset Management, LLC, VANGUARD GROUP INC, Laurion Capital Management LP, Redmile Group, LLC, Blue Owl Capital Holdings LP, and TRV GP IV, LLC.
This table shows the top 133 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.